<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03572413</url>
  </required_header>
  <id_info>
    <org_study_id>NL65290.091.18 substudy</org_study_id>
    <nct_id>NCT03572413</nct_id>
  </id_info>
  <brief_title>The Effect of Low Pressure Pneumoperitoneum During Laparoscopic Colorectal Surgery on Innate Immune Homeostasis.</brief_title>
  <acronym>RECOVER-PLUS</acronym>
  <official_title>The Effectiveness of Low Pressure Pneumoperitoneum During Laparoscopic Colorectal Surgery in Preserving Innate Immune Homeostasis by Reducing Peritoneal Mesothelial Cell Injury.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Radboud University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Merck Sharp &amp; Dohme Corp.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Radboud University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Substudy of the RECOVER trial (a randomised controlled trial comparing the effect of low
      pressure pneumoperitoneum with deep neuromuscular block versus normal pressure
      pneumoperitoneum with moderate neuromuscular block during laparoscopic colorectal surgery on
      early quality of recovery) investigating innate immune homeostasis after laparoscopic
      colorectal surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Rationale: increased intra-abdominal pressure can cause peritoneal mesothelial cell injury
      either directly or by compression of the capillary vessels, causing a variable degree of
      ischemia reperfusion injury. The immune system can identify damage to host cells by
      recognising Danger-Associated Molecular Patterns (DAMPs) that are released upon cell death in
      an uncontrolled fashion, such as during surgical trauma. DAMPs elicit an immune response
      similar to the response to invading pathogens and induce an anti-inflammatory immune response
      strongly related to postoperative recovery, infectious complications and mortality. Low
      pressure PNP is associated with lower levels of serum pro- and anti-inflammatory cytokines
      and better preservation of innate immune function.

      Objective: to establish the relationship between the use of low pressure pneumoperitoneum
      with deep neuromuscular blockade and innate immune function after laparoscopic colorectal
      surgery.

      Study design: a multi-center, blinded, randomized controlled clinical trial.

      Study population: adult individuals scheduled for laparoscopic colorectal surgery with a
      primary colonic anastomosis.

      Intervention: participants will be randomly assigned in a 1:1 fashion to either the
      experimental group (group A): low pressure PNP (8 mmHg) with deep NMB (PTC 1-2) or the
      control group (group B): normal pressure PNP (12 mmHg) with moderate NMB (TOF count 1-2).

      Primary endpoint: mononuclear cell responsiveness ex-vivo as reflected by IL-6 and IL-10
      release upon LPS stimulation.

      Secondary endpoints: peritoneal mesothelial hypoxia as reflected by peritoneal HIF1α mRNA
      expression, histological peritoneal mesothelial cell injury and plasma levels of DAMPs and
      cytokines.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 24, 2018</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mononuclear cell responsiveness ex vivo</measure>
    <time_frame>Before surgery, 24 and 72 hours after surgery</time_frame>
    <description>IL-6 and IL-10 release upon LPS stimulation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Serum DAMPs and cytokines</measure>
    <time_frame>Before surgery, at the end of surgery and 24 hours after surgery</time_frame>
    <description>Danger associated molecular patterns, IL-6 and IL-10</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Monocyte HLA-DR expression</measure>
    <time_frame>Before surgery, 24 and 72 hours after surgery</time_frame>
    <description>MHC-II antigen presenting immune receptor on monocytes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peritoneal histology and HIF1alpha expression</measure>
    <time_frame>At the start and end of surgery</time_frame>
    <description>Histology and HIF1alpha mRNA expression of a peritoneal biopsy</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Pneumoperitoneum</condition>
  <condition>Neuromuscular Blockade</condition>
  <condition>Surgery</condition>
  <condition>Immune Suppression</condition>
  <arm_group>
    <arm_group_label>Low pressure PNP, deep NMB</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Low pressure pneumoperitoneum of 8 mmHg with deep neuromuscular block (post tetanic count of 1-2) reached by titration with continuous infusion of Rocuronium bromide.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal pressure PNP, moderate NMB</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Normal pressure pneumoperitoneum of 12 mmHg with moderate neuromuscular block (TOF count of 1-2) reached by titration with bolus or continuous infusion of a low dose of Rocuronium bromide.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Low pressure pneumoperitoneum</intervention_name>
    <description>Lowering intra-abdominal pressure during laparoscopic surgery</description>
    <arm_group_label>Low pressure PNP, deep NMB</arm_group_label>
    <other_name>Low intra-abdominal pressure</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Rocuronium bromide</intervention_name>
    <description>Deep (PTC 1-2) versus moderate (TOF count 1-2) neuromuscular block</description>
    <arm_group_label>Low pressure PNP, deep NMB</arm_group_label>
    <arm_group_label>Normal pressure PNP, moderate NMB</arm_group_label>
    <other_name>Deep muscle relaxation</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Scheduled for laparoscopic colorectal surgery with a primary anastomosis

          -  Obtained informed consent

          -  Age over 18 years

        Exclusion Criteria:

          -  Insufficient control of the Dutch language to read the patient information and to fill
             out the questionnaires

          -  Primary colostomy

          -  Neo-adjuvant chemotherapy

          -  Chronic use of analgesics or psychotropic drugs

          -  Use of NSAIDs shorter than 5 days before surgery

          -  Known or suspected allergy to rocuronium of sugammadex

          -  Neuromuscular disease

          -  Indication for rapid sequence induction

          -  Severe liver- or renal disease (creatinine clearance &lt;30ml/min)

          -  BMI &gt;35 kg/m²

          -  Deficiency of vitamin K dependent clotting factors or coagulopathy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kim I Albers, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Radboud University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michiel C Warlé, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Radboud University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kim I Albers, MD</last_name>
    <phone>(+31)24 36 17612</phone>
    <email>kim.albers@radboudumc.nl</email>
  </overall_contact>
  <location>
    <facility>
      <name>Canisius Wilhelmina Hospital</name>
      <address>
        <city>Nijmegen</city>
        <state>Gelderland</state>
        <zip>6532SZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kim I Albers, MD</last_name>
      <phone>0031617171996</phone>
      <email>kim.albers@radboudumc.nl</email>
    </contact>
    <contact_backup>
      <last_name>Michiel C Warle, MD, PhD</last_name>
      <email>michiel.warle@radboudumc.nl</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>June 18, 2018</study_first_submitted>
  <study_first_submitted_qc>June 18, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 28, 2018</study_first_posted>
  <last_update_submitted>April 17, 2020</last_update_submitted>
  <last_update_submitted_qc>April 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Laparoscopic surgery</keyword>
  <keyword>Deep neuromuscular block</keyword>
  <keyword>Low pressure pneumoperitoneum</keyword>
  <keyword>Postoperative immune suppression</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumoperitoneum</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bromides</mesh_term>
    <mesh_term>Rocuronium</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

